| # | Drug | Count |
|---|---|---|
| 0 | AMOXICILLIN | 14 |
| 1 | METHOTREXATE SODIUM | 12 |
| 2 | GOLIMUMAB | 11 |
| 3 | INFLIXIMAB | 10 |
| 4 | METHOTREXATE | 10 |
| 5 | IBUPROFEN | 8 |
| 6 | ONDANSETRON HYDROCHLORIDE | 8 |
| 7 | AFLIBERCEPT | 7 |
| 8 | AZATHIOPRINE | 7 |
| 9 | DEXAMETHASONE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORZOXAZONE | 2 | 0.0015 |
| 1 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 2 | PROPYLTHIOURACIL | 3 | 0.0014 |
| 3 | IDURSULFASE | 5 | 0.0013 |
| 4 | GOLIMUMAB | 11 | 0.0009 |
| 5 | PENICILLIN G | 2 | 0.0009 |
| 6 | CEFOTAXIME INJECTION | 3 | 0.0007 |
| 7 | DEFERIPRONE | 2 | 0.0006 |
| 8 | MITOTANE | 1 | 0.0005 |
| 9 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 7 | 0.0005 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 3 | Interleukin-17A Antagonist [EPC] | 7 | 0.0002 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Vitamin K [EPC] | 1 | 0.0001 |
| 8 | Iron Chelator [EPC] | 3 | 0.0001 |
| 9 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |